(NEW YORK)Shares of Genzyme Corp. fell Wednesday after the company reported positive second-quarter financial results but said plans to increase production of its genetic disorder drug Myozy...READ MORE
(CAMBRIDGE, Mass.)Biotechnology company Genzyme Corp. said Wednesday its second-quarter profit fell on a series of charges, though adjusted profit and revenue topped Wall Street forecasts.READ MORE
(NEW YORK)Shares throughout the biotechnology sector advanced Monday as Swiss pharmaceutical giant Roche offered to buy Genentech Inc. in potentially the biggest pharma-biotech deal of the y...READ MORE
(WASHINGTON)A Minnesota family is trying to force a New Jersey drug company to give their son an experimental drug for a fatal form of muscular dystrophy, saying he'll die without it.READ MORE
(CAMBRIDGE, Mass.)Biotechnology company Genzyme Corp. said Thursday it will pay PTC Therapeutics Inc. $100 million upfront to license rights to a developing treatment for genetic disorders.READ MORE
(NEW YORK)Drug company sales representatives will have to stop doling out coffee mugs and pens that push their products when they visit doctor's offices. But they can still sneak in the occa...READ MORE